The talc powder Shower-to-Shower, manufactured by Johnson & Johnson, has been linked to ovarian cancer. Additional testing on women with ovarian cancer has shown residue of talc fibers in the ovary, suggesting that talcum can move through the vagina, uterus, fallopian tubes, and into the ovaries.
This product is marketed as an after-shower hygiene product to absorb moisture and reduce odor. It has been on the market for decades and has brought Johnson & Johnson great revenue.
Some of the symptoms of ovarian cancer are abnormal vaginal discharge, vaginal bleeding, pain in abdomen or pelvis, frequent bloating, abdominal pressure, fullness or swelling, persistent fatigue, constipation or frequent urination, among others.
In May 2016 a jury awarded $55 Million to a woman that suffered from ovarian cancer as a result of the long-term use of this product. Johnson & Johnson has decided to challenge this decision.